In late November Abbott—one of Dexcom’s main competitors— recalled some of its CGMs due to inaccurate low glucose readings.

About 3 million glucose monitoring sensors were potentially affected by a production error that caused incorrect low glucose readings.

A new alert from the FDA warns that some sensors from Abbott may give incorrect blood sugar readings, which could lead to adverse events.

The Food and Drug Administration has issued an Early Alert in response to “a potentially high-risk issue” concerning faulty ...

Synthesis of nanostructured cubic phase SnO 2 thin film and its trace-level sensing of CO gas This study presents a cubic phase SnO 2 thin film gas sensor with ultra-high CO sensitivity and 1 ppb ...

Some alternatives for hormone therapy (HT) may help manage menopause symptoms. Examples include diet and lifestyle changes, supplements, and exercise. Hormone therapy (HT) is generally an effective ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Trailing total returns as of 12/9/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) Return TON.AX S&P/ASX 200 [XJO] (^AXJO) ...